Patient Research Platforms
Cancer specific Health Companions collect validated Patient Reported Outcomes Measures (PROMs) from patients outside routine clinical practice. Allowing patients to take control in the management of their cancer by enabling them to record, monitor and communicate how they feel. To support improvements in healthcare services, patient outcomes and research into new medicines
The Digital Assessment Xchange (DAX) has been developed as a mechanism for continuous research into validated Patient Reported Outcomes Measures (PROMs). By linking into national medical records, ‘unique’ real-world studies can be undertaken to provide cost efficient, timely & precise evidence for the reimbursement and regulatory approval of new medicines.
DaSH Global partners with pharmaceutical companies to provide linked access to DAX data and national medical records. Delivering 'protocol approved' real-world research studies with full analytical services.
DaSH Global look to enhance the drug approval process through the power of delivering cost-efficient, timely and precise evidence from unique real-world research methodologies.
Specialising in MedTech strategies & products through our vision of building collaborative ‘disruptive’ transformational research platforms from ‘joined up’ health care.
"Disruptive digital technology sounded good!? But now I’ve got my head around all the benefits this service has for our patients, nurses, and the charity, this is a real game changer".
Head of Services Mesothelioma UK
Liz Darlison MBE EN RN BSc MSc
Get in touch.
Riverside Mill, Mountbatten Way, Congleton
Cheshire CW12 1DY
t: +44 (0)7540 724927
56 Greek Street
London W1D 3DU
t: +44 (0)7803 036552